Healthcare / Medical Care FacilitiesNYSE
$4.64
+0.03 (+0.77%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $517.8M · quality 48.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
32/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$344M
P/E
16.9x
↓EV/EBITDA
4.3x
↓ROE
6.1%
↑Gross Margin
37.9%
↓Debt/Equity
2.28
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+21.4%
FCF CAGR
+264.7%
FCF margin
11.8%
FCF / Net income
5.30x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $4.39B · net income $97.6M · FCF $517.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $4.39B | $4.39B | $4.39B | $3.88B | $2.45B |
| Net Income | $97.6M | $97.6M | $110.3M | $-253.9M | $-85.6M |
| EBITDA | $856.7M | $856.7M | $887.0M | $647.3M | $299.1M |
| EPS | 1.32 | 1.32 | 1.63 | -3.44 | -1.16 |
| Gross Margin | 37.9% | 37.9% | 39.3% | 37.0% | 35.9% |
| Operating Margin | 14.4% | 14.4% | 17.0% | 14.1% | 9.9% |
| Net Margin | 2.2% | 2.2% | 2.5% | -6.6% | -3.5% |
| Balance Sheet | |||||
| Debt/Equity | 2.28 | 2.28 | 2.55 | 2.67 | 3.30 |
| Current Ratio | 1.09 | 1.09 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $517.8M | $517.8M | $526.6M | $417.2M | $10.7M |
| Returns | |||||
| ROE | 6.1% | 6.1% | 7.5% | -17.3% | -8.0% |
| Valuation | |||||
| P/E | 16.94 | 16.94 | 4.30 | — | — |
| EV/EBITDA | 4.27 | 4.27 | 4.52 | — | — |
| P/B | 0.21 | 0.21 | 0.32 | — | — |
| Growth & Yield | |||||
| Revenue Growth | -0.0% | -0.0% | 13.2% | 58.1% | — |
| EPS Growth | -19.0% | -19.0% | 147.5% | -196.6% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
-32.2%
EPS terminal req.
$0.41
Spread vs growth
13.2%
5Y implied EPS CAGR
-17.7%
EPS terminal req.
$0.50
Spread vs growth
-1.3%
10Y implied EPS CAGR
-4.9%
EPS terminal req.
$0.80
Spread vs growth
-14.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-29.7%
Start / end P/E
4.0x → 3.5x
EPS bridge
1.63 → 1.32
Residual
+2.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.